Connect Sign In
The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care.
ARUP and other clinical labs anxiously await a decision by a federal court in Texas about whether the FDA overstepped its statutory authority.
Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes whole genome sequencing can provide answers and improve cardiac care for all.
February is National Cancer Prevention Month. ARUP Consult provides guidance on hereditary cancer germline genetic testing for early detection and management of inherited cancer syndromes.
The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.
ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.
ARUP Healthcare Advisory Services can help labs prepare for the quality management system requirements in the FDA’s final rule on laboratory-developed tests, despite the rule’s uncertain future.
ARUP supported 15 families resettling in Utah through the International Rescue Committee’s Light One Candle initiative with donations that included toys, toiletries, and TVs.
ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).
Benjamin Bradley, MD, PhD, compared the H5N1 outbreak to COVID-19, highlighting the preparedness of labs and the CDC’s proactive approach during a media briefing.
